Optimisation of mammographic breast cancer screening using a computer simulation model

European Journal of Radiology

Volumn 24, Issue 2, 1997, Pages 137-144

  Jansen, J Th M ^a   Zoetelief, J ^a  

^a TNO   (Netherlands)

Author keywords

breast cancer screening; breast screening protocols; mammography; optimisation; risk benefit analysis

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL TRIAL; COMPUTER SIMULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAMMOGRAPHY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; COMPUTER SIMULATION; FEMALE; FORECASTING; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; RADIATION DOSAGE; RADIOGRAPHIC IMAGE ENHANCEMENT; RISK; RISK FACTORS; SWEDEN;

EID: 0031080223     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(96)01054-6     Document Type: Article

References (18)

1. [1] Tabár L, Fagerberg G, Day NE et al. Breast cancer treatment and natural history: new insights from results of screening. The Lancet 1992; 339: 412-414.
2. [2] Peeters PHM, Verbeek ALM, Hendriks JHCL et al. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 1989; 59: 929-932.
3. [3] Frisell J, von Rosen A, Wiege M et al. Interval cancer and survival in a randomized breast cancer screening trial in Stockholm. Breast Cancer Research and Treatment 1992; 24: 11-16.
4. [4] Day NE, Screening for breast cancer. British Medical Bulletin 1991; 47: 400-415.
5. [5] Andersson I, Aspegren K, Janzon L et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988; 297: 943-948.
6. [6] Jansen JThM, Zoetelief J. MBS: a Model for risk benefit analysis of Breast cancer Screening. Br J Radiol 1995; 68: 141-149.
7. [7] Miller AB, Howe GR, Sherman GJ et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. The New England Journal of Medicine 1989; 321: 1285-1289.
8. [8] Brenner DJ. Amols HI. Enhanced risk from low-energy screen-film mammography X rays. Br J Radiol 1989; 62: 910-914.
9. [9] Duffy SW, Tabar L, Fagerberg G et al. Breast screening, prognostic factors and survival-results from the Swedish two county study. Br J Cancer 1991; 64: 1133-1138.
10. [10] Charit A, Malaise EP, Tubiana M. Relation between the pathological nature and the growth rate of human tumors. Europ J Cancer 1971; 7: 307-315.
11. [11] Lee Y-TN, Spratt JS. Rate of growth of soft tissue metastases of breast cancer. Cancer 1972; 29: 344-348.
12. [12] Kusama S, Spratt JS, Donegan WL et al. The gross rates of growth of human mammary carcinoma. Cancer 1972; 30: 594-599.
13. [13] Pearlman AW. Breast cancer-Influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrence. Cancer 1976; 38: 1826-1833.
14. [14] Lundgren B. Observations on growth rate of breast carcinomas and its possible implications for lead time. Cancer 1977; 40: 1722-1725.
15. [15] Heuser L, Spratt JS, Polk HC. Growth rates of primary breast cancers. Cancer 1979; 43: 1888-1894.
16. [16] Fournier DV, Weber E, Hoeffken W et al. Growth rate of 147 mammary carcinomas. Cancer 1980; 45: 2198-2207.
17. [17] Arnerlöv C, Emdin SO, Lundgren B et al. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population. Cancer 1992; 70: 1928-1934.
18. [18] Peer PGM, van Dijck JAAM, Hendriks JHCL et al. Age-dependent growth rate of primary breast cancer. Cancer 1993; 71: 3547-3551.